Search Results - "Jensen, Anders B."

Phase III Randomized Study Comparing Docetaxel Plus Trastuzumab With Vinorelbine Plus Trastuzumab As First-Line Therapy of Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: The HERNATA Study by ANDERSSON, Michael, LIDBRINK, Elisabeth, BERGH, Jonas, LANGKJER, Sven T, BJERRE, Karsten, WIST, Erik, ENEVOLDSEN, Kristin, JENSEN, Anders B, KARLSSON, Per, TANGE, Ulla B, SØRENSEN, Peter G, MØLLER, Susanne

“…To evaluate docetaxel or vinorelbine, both with trastuzumab, as first-line therapy of human epidermal growth factor receptor 2-positive advanced breast cancer…”
Get full text

ConquerFear-Group: A randomized controlled trial of an online-delivered group-based psychological intervention for fear of cancer recurrence in breast cancer survivors by Tauber, Nina M, O'Toole, Mia S, Jensen, Anders B, Butow, Phyllis N, Thewes, Belinda, Elkjaer, Emma, Knutzen, Sofie, von Heymann, Annika, Johansen, Christoffer, Zachariae, Robert

“…Fear of cancer recurrence (FCR) is a distressing concern among cancer survivors. Interventions to address FCR need to be effective but also accessible and low…”
Get full text

Chronic Pain and Neuropathy Following Adjuvant Chemotherapy by Ventzel, Lise, Madsen, Caspar S, Karlsson, Páll, Tankisi, Hatice, Isak, Baris, Fuglsang-Frederiksen, Anders, Jensen, Anders B, Jensen, Anni R, Jensen, Troels S, Finnerup, Nanna B

“…Abstract Objective To determine symptoms and characteristics of chronic sensory neuropathy in patients treated with oxaliplatin and docetaxel, including…”
Get full text

Expressive writing intervention and self-reported physical health out-comes - Results from a nationwide randomized controlled trial with breast cancer patients by Jensen-Johansen, Mikael B, O'Toole, Mia S, Christensen, Søren, Valdimarsdottir, Heiddis, Zakowski, Sandra, Bovbjerg, Dana H, Jensen, Anders B, Zachariae, Robert

“…The objective was to examine the effect of Expressive Writing Intervention (EWI) on self-reported physical symptoms and healthcare utilization in a nationwide…”
Get full text

Increase in clinically recorded type 2 diabetes after colectomy by Jensen, Anders B, Sørensen, Thorkild Ia, Pedersen, Oluf, Jess, Tine, Brunak, Søren, Allin, Kristine H

“…The colon hosts gut microbes and glucagon-like peptide 1 secreting cells, both of which influence glucose homeostasis. We tested whether colectomy is…”
Get full text

Prevalence and Predictors of Sleep Difficulty in a National Cohort of Women With Primary Breast Cancer Three to Four Months Postsurgery by Colagiuri, Ben, PhD, Christensen, Søren, MSc, Jensen, Anders B., PhD, Price, Melanie A., PhD, Butow, Phyllis N., PhD, Zachariae, Robert, MDSci

“…Abstract Context Mounting evidence suggests that many cancer patients suffer from sleep difficulty, but there is conflicting evidence regarding the prevalence…”
Get full text

Long‐term symptoms of polyneuropathy in breast and colorectal cancer patients treated with and without adjuvant chemotherapy by Bennedsgaard, Kristine, Ventzel, Lise, Themistocleous, Andreas C., Bennett, David L., Jensen, Anders B., Jensen, Anni R., Andersen, Niels T., Jensen, Troels S., Tankisi, Hatice, Finnerup, Nanna B.

“…Background The aim of this study was to assess chemotherapy‐induced polyneuropathy (CIPN) 5 years after adjuvant chemotherapy in patients with breast and…”
Get full text

Identifying bereaved subjects at risk of complicated grief: Predictive value of questionnaire items in a cohort study by Guldin, Mai-Britt, O'Connor, Maja, Sokolowski, Ineta, Jensen, Anders B, Vedsted, Peter

“…Bereavement is a condition which most people experience several times during their lives. A small but noteworthy proportion of bereaved individuals experience…”
Get full text

Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel by Ventzel, Lise, Jensen, Anders B., Jensen, Anni R., Jensen, Troels S., Finnerup, Nanna B.

“…Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of cancer therapy. This study evaluates symptoms of CIPN and CIPN-related pain and…”
Get full text

A Large-Cohort, Longitudinal Study Determines Precancer Disease Routes across Different Cancer Types by Hu, Jessica X, Helleberg, Marie, Jensen, Anders B, Brunak, Søren, Lundgren, Jens

“…Although many diseases are associated with cancer, the full spectrum of temporal disease correlations across cancer types has not yet been characterized. A…”
Get full text

Klinefelter syndrome comorbidities linked to increased X chromosome gene dosage and altered protein interactome activity by Belling, Kirstine, Russo, Francesco, Jensen, Anders B, Dalgaard, Marlene D, Westergaard, David, Rajpert-De Meyts, Ewa, Skakkebæk, Niels E, Juul, Anders, Brunak, Søren

“…Klinefelter syndrome (KS) (47,XXY) is the most common male sex chromosome aneuploidy. Diagnosis and clinical supervision remain a challenge due to varying…”
Get full text

Diffusion gradient nonlinearity bias correction reduces bias of breast cancer bone metastasis ADC values by Buus, Thomas W., Jensen, Anders B., Pedersen, Erik M.

“…Contract grant sponsor Health Research Fund of Central Denmark Region. Background Diffusion gradient nonlinearity (DGNL) bias causes apparent diffusion…”
Get full text

Mindfulness-based Cognitive Therapy and Persistent Pain in Women Treated for Primary Breast Cancer: Exploring Possible Statistical Mediators: Results From a Randomized Controlled Trial by Johannsen, Maja, O’Connor, Maja, O’Toole, Mia S, Jensen, Anders B, Zachariae, Robert

“…OBJECTIVES:The aim of this study was to investigate possible statistical mediators in a randomized controlled trial of mindfulness-based cognitive therapy…”
Get full text

Preferred Place of Care and Death in Terminally Ill Patients with Lung and Heart Disease Compared to Cancer Patients by Skorstengaard, Marianne H, Neergaard, Mette A, Andreassen, Pernille, Brogaard, Trine, Bendstrup, Elisabeth, Løkke, Anders, Aagaard, Susanne, Wiggers, Henrik, Bech, Per, Jensen, Anders B

“…The dual aim of this study is, first, to describe preferred place of care (PPOC) and preferred place of death (PPOD) in terminally ill patients with lung and…”
Get more information

ConquerFear‐group: Feasibility study with pilot results of a psychological intervention for fear of cancer recurrence delivered in groups by Tauber, Nina M., Zachariae, Robert, Jensen, Anders B., Thewes, Belinda, Skyt, Ina, Elkjær, Emma, Butow, Phyllis N., O’Toole, Mia S.

“…Objective ConquerFear has been found to effectively reduce fear of cancer recurrence (FCR). Group interventions may be particularly effective for the treatment…”
Get full text

Congruence between preferred and actual place of care and death among Danish cancer patients by Brogaard, Trine, Neergaard, Mette A, Sokolowski, Ineta, Olesen, Frede, Jensen, Anders B

“…Background: Meeting patient’s preferences is an important outcome in palliative care. No Scandinavian study has reported systematically collected preferences…”
Get full text

Treatment of advanced HR+/HER2- breast cancer with new targeted agents in combination with endocrine therapy: a review of efficacy and tolerability based on available randomized trials on everolimus, ribociclib, palbociclib and abemaciclib by Bøttcher, Tea M, Cold, Søren, Jensen, Anders B

“…Recently, new targeted agents have been developed, which can prolong the effect of endocrine treatment (ET) by targeting resistance pathways in HR+/HER2-…”
Get more information

Cancer surviving patients' rehabilitation - understanding failure through application of theoretical perspectives from Habermas by Mikkelsen, Thorbjørn H, Soendergaard, Jens, Jensen, Anders B, Olesen, Frede

“…This study aims to analyze whether the rehabilitation of cancer surviving patients (CSPs) can be better organized. The data for this paper consists of focus…”
Get full text

Palliative treatment with carboplatin as late line therapy to patients with metastatic breast cancer by Rosvig, Lena H, Langkjer, Sven T, Knoop, Ann, Jensen, Anders B

Get more information

Prognostic utility of Fibrosis-4 Index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and/or type 2 diabetes: a longitudinal cohort study by Anstee, Quentin M, Berentzen, Tina L, Nitze, Louise M, Jara, Maximilian, Jensen, Anders B, Kjær, Mette S, Mangla, Kamal K, Tarp, Jens M, Khunti, Kamlesh

“…The Fibrosis-4 Index (FIB-4) is used as a non-invasive tool for the presence of advanced liver fibrosis in metabolic dysfunction-associated steatotic liver…”
Get full text